Bibliografía: 

1.       Mueller C, Laule-Kilian K, Frana B et al. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. American Heart Journal 2006; 151 (2):471-477

2.       Leuchte H, Baumgartner R, El Nounou M. et al. Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease. Am J Respir Crit Care Med 2006; 173: 744–750  

3.       McLean AS, Huang S. The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care 2005; 11:406—412.

4.       Morrison LK , Harrison A, Krishnaswamy P. Utility of a Rapid B-Natriuretic Peptide Assay in Differentiating Congestive Heart Failure from Lung Disease in Patients Presenting With Dyspnea. Journal of the American College of Cardiology 2002; 39 (2):202-209

5.       Mueller C, Scholer A, Laule-Kilian K et al. Use of B-Type Natriuretic Peptide in   the Evaluation and Management of Acute Dyspnea. N Engl J Med 2004;350:647-54.

6.       Provenchère S, Berroeta C, Reynaud C et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34 (4):995–1000

7.       Winter WE, Elin RJ. The role and assessment of ventricular peptides in heart failure. Clin Lab Med. 2004; 24: 235–274